- Supported exchanges /
- KQ /
- 023910.KQ
Daihan Pharmaceutical Co.Ltd (023910 KQ) stock market data APIs
₩26350
150(0.6%)
as of November 22, 2024
Price chart is built with Anychart
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
Daihan Pharmaceutical Co.Ltd Financial Data Overview
| 26200 | |
| 26350 | |
| - | |
| 26350 | |
| 26000 | |
| 23750-29650 | |
| 154 056 M | |
| 5 880 K | |
| 198 052 M | |
| 1443.2058 | |
| 0.029 | |
| 0.217 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'023910',
Type:
'Common Stock',
Name:
'Daihan Pharmaceutical Co.Ltd',
Exchange:
'KQ',
CurrencyCode:
'KRW',
CurrencyName:
'Korean Won',
CurrencySymbol:
'₩',
CountryName:
'Korea',
CountryISO:
'KR',
OpenFigi:
'BBG000C1MB31',
ISIN:
'KR7023910003',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - Specialty & Generic',
}
Daihan Pharmaceutical Co.Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 198 052 M
- EBITDA 44 064 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Daihan Pharmaceutical Co.Ltd Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Daihan Pharmaceutical Co.Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
